Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

TAVR valve for AR , a recent Edwards acquisition, delivers long-term value
The J-Valve System is associated with positive 10-year outcomes for patients with severe AR, according to new research out of China. It also performs well in patients with severe AS.
Cardiologist impressed by experimental pill that significantly lowers cholesterol
An experimental oral PCSK9 inhibitor is associated with LDL-C reductions that could prove to be a game-changer for patient care.
Cardiologists urge Congress to pass new bills focused on PAD, Medicare coverage
SCAI has shared a new call to action as an observance of American Heart Month. The group is asking Congress to pass new pieces of legislation that could improve care for PAD patients and get important medical devices in the hands of interventional cardiologists.
FDA announces recall of Johnson & Johnson devices after multiple injuries, 1 death
Several detachable coil systems are being recalled due to a higher-than-expected failure to detach rate. Customers should not use them going forward.
New recall includes nearly 23K bottles of triglycerides drug used to treat heart disease
New Jersey-based Zydus Pharmaceuticals has recalled nearly 23,000 bottles of its icosapent ethyl capsules due to leakage issues that may have weakened their effectiveness.

Blue light shows promise for reducing blood pressure

Exposure to blue light could decrease an individual’s systolic blood pressure by as much as 8 mm Hg in just half an hour, researchers report in a study co-led by the University of Surrey, Heinrich Heine University Düsseldorf and Philips.

Just 5% of T1D patients in UK have insured access to flash glucose monitors

Up to a quarter of type 1 diabetes patients in England should have access to the Freestyle Libre, a flash glucose monitor that allows diabetics to check their blood sugar without the need for finger pricks. But a recent investigation by the BMJ has concluded that, in reality, just 3 to 5 percent of eligible patients have access to the potentially life-changing technology.

Teens face up to 7 times higher odds of AMI with cocaine, cannabis use

Cocaine, amphetamines and cannabis could raise adolescents’ risk for acute myocardial infarction (AMI), in some cases increasing a teen’s odds for MI by up to seven times, according to research out of Shanghai Jiao Tong University School of Medicine in China.

Large nighttime meals tied to hypertension, prediabetes

It’s not just what people eat—but when—that may influence their risk of developing prediabetes and high blood pressure, according to preliminary research scheduled to be presented Nov. 10 at the American Heart Association’s Scientific Sessions in Chicago.

DOACs cut dementia risk in AFib patients more than warfarin

For patients with nonvalvular atrial fibrillation (AFib), taking a direct oral anticoagulant (DOAC) instead of warfarin may cut the risk of dementia by 15 to 20 percent, according to a large database study published Nov. 2 in the Journal of the American Heart Association.

Stress of violent crime spikes BP rates, even in safe neighborhoods

Climbing rates of violent crime could trigger blood pressure (BP) spikes within nearby communities—particularly among individuals living in what are considered “safe” neighborhoods—according to a study of 50,000 adults living in Chicago.

Lower health literacy linked to higher mortality in acute decompensated HF

Poor health literacy could mean an increased risk of death for patients hospitalized with acute decompensated heart failure (ADHF), according to a study published in Mayo Clinic Proceedings Nov. 7.

Medtronic Begins Renal Denervation Study for High Blood Pressure Patients Prescribed Anti-Hypertensive Medication

Medtronic announced U.S. Food and Drug Administration (FDA) approval to begin a clinical trial to evaluate the Symplicity Spyral renal denervation system in patients with high blood pressure (hypertension) who are already prescribed anti-hypertension medications.

Clinical

TAVR valve for AR , a recent Edwards acquisition, delivers long-term value

Cardiologist impressed by experimental pill that significantly lowers cholesterol

Cardiologists urge Congress to pass new bills focused on PAD, Medicare coverage

FDA announces recall of Johnson & Johnson devices after multiple injuries, 1 death

New recall includes nearly 23K bottles of triglycerides drug used to treat heart disease